natgillin/translations-raw huggingface dataset:
If you are not sure how much medicine to take, always ask your doctor or nurse. 
Če niste prepričani, kakšen odmerek zdravila morate vzeti, vprašajte svojega zdravnika ali medicinsko sestro.
This problem could be exacerbated by coadministration with active substances that inhibit TPMT, such as olsalazine, mesalazine or sulfasalazine. 
Sočasna uporaba učinkovin, ki zavirajo TPMT, kot so olsalazin, mesalazin ali sulfasalazin, lahko to težavo še poslabša.
Gently put the tip of the syringe into your mouth and to the inside of your cheek. 
Konico brizge nežno položite v usta, proti notranji strani lica.
Since there is a potential for reduced elimination of mercaptopurine, consideration should be given to reduced starting doses in patients with impaired hepatic function. 
Ker obstaja možnost zmanjšanega izločanja merkaptopurina, je pri bolnikih z okvarjenim delovanjem jeter treba razmisliti o zmanjšanju začetnega odmerka.
They generally require dose reduction, particularly those being NUDT15 variant homozygotes (see 4.2). 
Običajno je potrebno zmanjšanje odmerka, predvsem pri bolnikih s homozigotnimi variantami NUDT15 (glejte poglavje 4.2).
Parents and care givers should avoid Xaluprine contact with skin or mucous membrane. 
Varno ravnanje s suspenzijo Starši in negovalci se morajo izogibat stiku zdravila Xaluprine s kožo ali sluznico.
Patients should be closely monitored for dose related adverse reactions. 
Pri bolnikih je treba skrbno spremljati morebiten pojav neželenih učinkov, povezanih z odmerkom.
- Do not take Xaluprine if you are allergic (hypersensitive) to mercaptopurine or any of the other ingredients of Xaluprine (see section 6). 
Kaj morate vedeti, preden boste vzeli zdravilo Xaluprine - Ne jemljite zdravila Xaluprine, če ste alergični na (preobčutljivi za) merkaptopurin ali katero koli drugo sestavino zdravila Xaluprine (glejte poglavje 6).
Turn the bottle back the right way up and carefully remove the syringe from the adaptor, holding it by the barrel rather than the plunger. 
Steklenico ponovno postavite v pokončni položaj in previdno odstranite brizgo iz nastavka, tako da držite brizgo in ne bata.
The active substance is mercaptopurine (as monohydrate). 
Učinkovina je merkaptopurin (v obliki monohidrata).
One ml of suspension contains 20 mg of mercaptopurine monohydrate. 
En ml suspenzije vsebuje 20 mg merkaptopurin monohidrata.
- tumours, including skin cancer. 
Novotvorbe, vključno z limfoproliferativnimi boleznimi, kožnim rakom
If Xaluprine comes into contact with skin or mucosa, it should be washed immediately and thoroughly with soap and water. 
Če pride zdravilo Xaluprine v stik s kožo ali sluznico, jo je treba takoj temeljito izprati z milom in vodo.
- Do not get vaccinated with yellow fever vaccine whilst you are taking Xaluprine because it may be fatal. 
- Med jemanjem zdravila Xaluprine ne smete prejeti cepiva proti rumeni mrzlici, saj je lahko to smrtno nevarno.
Cases of symptomatic hypoglycaemia have been reported in children with ALL receiving 6-mercaptopurine (see section 4.8). 
Pri otrocih z ALL, ki so prejemali 6-merkaptopurin, so poročali o primerih simptomatske hipoglikemije (glejte poglavje 4.8).
Cross-resistance usually exists between 6-mercaptopurine and 6-thioguanine. 
Med 6-merkaptopurinom in 6-tiogvaninom običajno obstaja navzkrižna odpornost.
The incidence of hepatotoxicity varies considerably and can occur with any dose but more frequently when the recommended dose is exceeded. 
Pojavnost hepatotoksičnosti se bistveno razlikuje in se lahko pojavi pri katerem koli odmerku,
Cytotoxic agents may decrease the intestinal absorption of phenytoin. 
Citotoksična zdravila lahko zmanjšajo absorpcijo fenitoina v prebavilih.
How to take Xaluprine 
Kako jemati zdravilo Xaluprine
Mutagenicity and carcinogenicity 
Mutagenost in kancerogenost
Pancreatitis in off-label treatment of patients with inflammatory bowel disease Pancreatitis has been reported to occur at a frequency of ≥ 1/100 to < 1/10 (“common”) in patients treated for the unlicensed indication inflammatory bowel disease. 
Poročali so, da se pankreatitis pojavlja s pogostostjo od ≥ 1/100 do < 1/10 („pogosto“) pri bolnikih, ki so jih zdravili zaradi vnetne bolezni črevesja, ki ni med indikacijami za uporabo tega zdravila.
Therefore, when taking Xaluprine, avoid excessive exposure to sunlight, wear protective clothing and use protective sunscreen with a high protection factor - lymphoproliferative disorders o treatment with Xaluprine increases your risk of getting a type of cancer called lymphoproliferative disorder. 
Zato se med jemanjem zdravila Xaluprine čim bolj izogibajte izpostavljenosti sončnim žarkom, nosite zaščitna oblačila in uporabljajte zaščitna sredstva za sončenje z visokim zaščitnim faktorjem.
Volume (ml) BSA (m2) Dose (mg) 
Prostorn ina (ml) TP (m2) Odmere k (mg)
Serum antiepileptic levels should be closely monitored during treatment with Xaluprine, making dose adjustments as necessary. 
Med zdravljenjem z zdravilom Xaluprine je treba pozorno spremljati ravni antiepileptikov v serumu in po potrebi prilagajati odmerke teh zdravil.
The main adverse reaction of treatment with 6-mercaptopurine is bone marrow suppression leading to leucopenia and thrombocytopenia. 
Glavni neželeni učinek pri zdravljenju s 6-merkaptopurinom je supresija kostnega mozga, ki vodi v levkopenijo in trombocitopenijo.
PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGING BOTTLE LABEL 
PODATKI NA STIČNI OVOJNINI NALEPKA NA STEKLENICI
Active measures (such as the use of activated charcoal or gastric lavage) may not be effective in the event of 6-mercaptopurine overdose unless the procedure can be undertaken within 60 minutes of ingestion. 
Aktivni ukrepi (kot so uporaba aktivnega oglja ali izpiranje želodca) morda ne bodo učinkoviti v primeru prevelikega odmerjanja
Xaluprine contains sucrose. 
Zdravilo Xaluprine vsebuje saharozo.
OTHER SPECIAL WARNING(S), IF NECESSARY Cytotoxic. 
DRUGA POSEBNA OPOZORILA, ČE SO POTREBNA Citotoksično zdravilo.
Genotypic testing of NUDT15 variants may be considered before initiating 6-mercaptopurine therapy. 
Pred uvedbo zdravljenja s 6-merkaptopurinom se lahko izvede genotipizacija variant NUDT15.
It is recommended that newborns of women exposed to mercaptopurine during pregnancy are monitored for haematological and immune system disturbances. 
Priporoča se, da se pri novorojenčkih mater, ki so bile med nosečnostjo izpostavljene merkaptopurinu,
Xaluprine also contains sodium methyl parahydroxybenzoate (E219) and sodium ethyl parahydroxybenzoate (E215) which may cause allergic reactions (possibly delayed). 
Zdravilo Xaluprine vsebuje tudi natrijev metilparahidroksibenzoat (E 219) in natrijev etilparahidroksibenzoat (E 215), ki lahko povzročita alergijske reakcije (lahko tudi zapoznele).
olsalazine, mesalazine or sulfazalazine) inhibit the TPMT enzyme, which metabolises 6-mercaptopurine, they should be administered with caution to patients receiving concurrent Xaluprine therapy (see section 4.4). 
Ker obstajajo dokazi in vitro, da derivati aminosalicilatov (npr. olsalazin, mesalazin ali sulfalazin) zavirajo encim TPMT, ki presnavlja 6-merkaptopurin, je potrebna posebna previdnosti pri njihovi sočasni uporabi pri bolnikih, ki prejemajo tudi zdravilo Xaluprine (glejte poglavje 4.4).
Hepatosplenic T-cell lymphoma has been reported in patients with inflammatory bowel disease* treated with azathioprine (the prodrug to 6-mercaptopurine) or 6-mercaptopurine, either with or without concomitant treatment with anti-TNF alpha antibody. 
Pri bolnikih z vnetno črevesno boleznijo*, zdravljenih z azatioprinom (predzdravilo 6-merkaptopurina) ali 6-merkaptopurinom, bodisi s sočasnim zdravljenjem s protitelesi proti TNF alfa ali brez njega, so poročali o jetrnovraničnem T-celičnem limfomu.
If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor or pharmacist. 
Nizka raven sladkorja v krvi (hipoglikemija) - pogostnost ni znana Če kateri koli neželeni učinek postane resen ali če opazite kateri koli neželeni učinek, ki ni omenjen v tem navodilu, obvestite svojega zdravnika ali farmacevta.
Slowly and gently push the plunger down to gently squirt the medicine into the inside of your cheek and swallow it. DO NOT forcefully push down the plunger, or squirt the medicine to the back of your mouth or throat, as you may choke. 
Počasi in nežno potisnite bat navzdol ter nežno iztisnite zdravilo v usta proti notranji strani lic in ga pogoltnite.
If you are not sure about how much medicine to draw into the syringe, always ask your doctor or nurse for advice. 
Če niste prepričani, koliko zdravila morate povleči v brizgo, se o tem posvetujete z zdravnikom ali medicinsko sestro.
Neoplasms including lymphoproliferative disorders, skin cancers (melanomas and non-melanomas), sarcomas (Kaposi's and non-Kaposi's) and uterine cervical cancer in situ (see section 4.4). 
(melanomskim in nemelanomskim), sarkomom (Kaposijevim in neKaposijevim) in rakom materničnega vratu in situ (glejte poglavje 4.4)
Xaluprine may be taken with food or on an empty stomach. 
Zdravilo Xaluprine se lahko vzame skupaj s hrano ali na tešče.
To decrease the risk of exposure disposable gloves should be used when handling Xaluprine. 
Za zmanjšanje tveganja izpostavljenosti pri uporabi zdravila Xaluprine vedno uporabljajte rokavice za enkratno uporabo.
Volume (ml) 
Prostorni na (ml)
Xaluprine may be taken with food or on an empty stomach, but patients should standardise the method of administration. 
Zdravilo Xaluprine se lahko jemlje s hrano ali na tešče, bolniki pa naj način uporabe poenotijo.
Other side effects (the frequency is unknown) - a rare type of cancer (hepatosplenic T-cell lymphoma), (see section 2, Warnings and 
- redka vrsta raka (jetrnovranični T-celični limfom) (glejte poglavje 2, Opozorila in previdnostni ukrepi)
Common (affects less than 1 in 10 people) - feeling or being sick (nausea or vomiting) - liver damage - this may show up in blood tests - a drop in red blood cells which may make you tired, weak or breathless (called anaemia) - loss of appetite - diarrhoea - inflammation of the mouth (stomatitis) 
Zelo pogosti (pojavijo se pri več kot 1 od 10 bolnikov) - zmanjšanje števila belih krvnih celic in trombocitov (lahko se pokaže pri krvnih preiskavah) Pogosti (pojavijo se pri manj kot 1 od 10 bolnikov) - občutek slabosti ali slabost (navzea ali bruhanje)
Patients with inherited mutated NUDT15 gene are at increased risk for severe 6-mercaptopurine toxicity, such as early leukopenia and alopecia, from conventional doses of thiopurine therapy. 
Bolniki z varianto NUDT15 Bolniki s podedovanim mutiranim genom NUDT15 so ob konvencionalnih odmerkih tiopurina izpostavljeni povečanemu tveganju za hudo toksičnost zaradi 6-merkaptopurina, kot sta zgodnja levkopenija in alopecija.
Do not stop taking your medicine unless your doctor tells you to or you may get a relapse of your condition. 
Če ste prenehali jemati zdravilo Xaluprine Ne prenehajte jemati zdravila, razen če vam je tako naročil zdravnik, saj se lahko bolezen ponovi.
Do not breast-feed while taking Xaluprine. 
Med jemanjem zdravila Xaluprine ne smete dojiti.
- Your doctor may sometimes change your dose of Xaluprine as a result of these tests. 
- Na podlagi izvidov teh testov lahko zdravnik občasno spremeni odmerek zdravila Xaluprine.
Since 6-mercaptopurine pharmacokinetics has not been formally studied in hepatic impairment, no specific dose recommendations can be given. 
Okvarjeno delovanje jeter Ker farmakokinetika 6-merkaptopurina pri okvarjenem delovanju jeter ni bila uradno raziskana, ni mogoče priporočiti določenega odmerka.
Effects of mercaptopurine on other medicinal products Concomitant administration of yellow fever vaccine is contraindicated, due to the risk of fatal disease in immunocompromised patients (see section 4.3) 
Sočasna uporaba s cepivom proti rumeni mrzlici je kontraindicirana zaradi tveganja za smrtno bolezen pri bolnikih z oslabljenim imunskim sistemom (glejte poglavje 4.3).
Xaluprine 20 mg/ml oral suspension mercaptopurine 
Xaluprine 20 mg/ml peroralna suspenzija merkaptopurin
Anyone handling Xaluprine should wash their hands before and after administering a dose. 
Pred uporabo odmerka zdravila Xaluprine in po njem je potrebno umivanje rok.
The other ingredients are xanthan gum, aspartame (E951), concentrated raspberry juice, sucrose, sodium methyl parahydroxybenzoate (E219), sodium ethyl parahydroxybenzoate (E215), potassium sorbate (E202), sodium hydroxide and purified water (see section 2 Xaluprine contains aspartame, sodium methyl parahydroxybenzoate (E219), sodium ethyl parahydroxybenzoate (E215) and sucrose). 
Druge sestavine so ksantanski gumi, aspartam (E951), koncentriran malinov sok, saharoza, natrijev metilparahidroksibenzoat (E 219), natrijev etilparahidroksibenzoat (E 215), kalijev sorbat (E 202), natrijev hidroksid in prečiščena voda (glejte poglavje 2 za dodatne informacije o aspartamu, natrijevem metilparahidroksibenzoatu (E 219), natrijevem etilparahidroksibenzoatu (E 215) in saharozi).
Contents of the pack and other information 
Shranjevanje zdravila Xaluprine Vsebina pakiranja in dodatne informacije
Therefore, Xaluprine may be taken with food or on an empty stomach, but patients should standardise the method of administration. 
Zato se lahko zdravilo Xaluprine jemlje s hrano ali na tešče, bolniki pa naj način uporabe poenotijo.
Xaluprine is cytotoxic. 
Zdravilo Xaluprin je citotoksično.
o A combination of multiple immunosuppressants, given concomitantly increases the risk of disorders of the lymph system due to a viral infection (Epstein-Barr virus (EBV)-associated lymphoproliferative disorders). 
o Kombinacija več imunosupresivnih zdravil, ki se dajejo sočasno, poveča tveganje za bolezni limfnega sistema zaradi virusne okužbe (limfoproliferativne bolezni,
Oral suspension. 
peroralna suspenzija
Discard 56 days after first opening. 
56 dni po prvem odpiranju zdravilo zavrzite.
The bioavailability of oral 6-mercaptopurine shows considerable inter-individual variability, which probably results from its first-pass metabolism. 
Biološka uporabnost peroralnega 6-merkaptopurina kaže pomembno variabilnost med posamezniki,
Talk to your doctor, pharmacist or nurse before taking Xaluprine if: - you have been vaccinated with yellow fever vaccine - you have kidney or liver problems, as your doctor will need to check that they are working properly. 
- ste bili cepljeni s cepivom proti rumeni mrzlici; - imate težave z ledvicami ali jetri - v tem primeru bo moral zdravnik preveriti, ali pravilno delujejo; - imate bolezen, pri kateri vaše telo proizvaja premalo encima TPMT (tiopurin metiltransferaza)
STATEMENT OF ACTIVE SUBSTANCE(S) One ml of suspension contains 20 mg mercaptopurine (as monohydrate). 
En ml suspenzije vsebuje 20 mg merkaptopurina (v obliki monohidrata).
More frequent monitoring may be advisable in those with pre-existing liver disease or receiving other potentially hepatotoxic therapy. 
Pri bolnikih z že obstoječo boleznijo jeter ali bolnikih, ki prejemajo druga potencialno hepatotoksična zdravila, se priporoča pogostejše spremljanje delovanja jeter.
Each pack contains one bottle, a bottle adaptor and two dosing syringes (a purple syringe graduated to 1 ml and a white syringe graduated to 5 ml). 
V vsakem pakiranju je ena steklenica, nastavek za steklenico in dve brizgi za odmerjanje (vijolična brizga z merilno skalo do 1 ml in bela brizga z merilno skalo do 5 ml).
Having vaccines while you are taking Xaluprine If you are going to have a vaccination it is important to speak to your doctor or nurse before you have it. Vaccination with live vaccines (like polio, measles, mumps and rubella) is not recommended, as these vaccines may give you an infection if you have them whilst you are taking Xaluprine. 
Cepljenje z živimi cepivi (npr. proti otroški paralizi, ošpicam, mumpsu in rdečkam) ni priporočljivo, saj lahko ta cepiva pri sočasni uporabi z zdravilom Xaluprine povzročajo okužbe.
- Allergic reaction, the signs may include: o skin rashes o high temperature o joint pain o swollen face 
Alergijske reakcije, ki imajo lahko naslednje znake: - kožni izpuščaj
* In patients with inflammatory bowel disease (IBD), an unlicensed indication. 
Prehodna oligospermija *Pri bolnikih z vnetno črevesno boleznijo, ki je indikacija brez odobritve.
Each pack contains one bottle, an HDPE bottle adaptor and 2 polyethylene dosing syringes (a purple syringe graduated to 1 ml and a white syringe graduated to 5 ml). 
V vsakem pakiranju je ena steklenica, nastavek HDPE za steklenico in 2 polietilenski brizgi za odmerjanje (vijolična brizga z merilno skalo do 1 ml in bela brizga z merilno skalo do 5 ml).
Put on disposable hand gloves before handling Xaluprine. 
Pred ravnanjem z zdravilom Xaluprine si nadenite rokavice za enkratno uporabo.
The expiry date refers to the last day of that month, - Do not store above 25°C. 
Rok uporabnosti zdravila se izteče na zadnji dan navedenega meseca.
- other cytotoxic medicines (chemotherapy) - when used with Xaluprine there is a greater chance of side effects, such as anaemia - allopurinol or febuxostat (used to treat gout) - oral anticoagulants (used to thin the blood) - olsalazine or mesalazine (used for a bowel disorder called ulcerative colitis) - sulfasalazine (used for rheumatoid arthritis or ulcerative colitis). 
- peroralne antikoagulante (uporabljajo se za redčenje krvi); - olsalazin ali mesalazin (uporablja se pri bolezni črevesja, imenovani ulcerozni kolitis)
What Xaluprine looks like and contents of the pack Xaluprine is a pink to brown oral suspension. 
Zdravilo Xaluprine je rožnata do rjava peroralna suspenzija.
Xaluprine is for oral use and requires redispersing (by shaking vigorously at least for 30 seconds) prior to dosing. 
Zdravilo Xaluprine je namenjeno peroralni uporabi in se mora pred odmerjanjem redispergirati
Transient profound oligospermia has been reported following exposure to 6-mercaptopurine in combination with corticosteroids. 
Po izpostavljenosti 6-merkaptopurinu v kombinaciji s kortikosteroidi so poročali o prehodni močni oligospermiji.
Your doctor or pharmacist will advise which syringe to use depending on the dose that has been prescribed. 
Glede na odmerek, ki vam je bil predpisan, vam bo zdravnik ali farmacevt svetoval, katero brizgo morate uporabiti.
Also contains: sodium methyl parahydroxybenzoate (E219), sodium ethyl parahydroxybenzoate (E215), potassium sorbate (E202), sodium hydroxide, aspartame (E951) and sucrose. 
Vsebuje tudi: natrijev metilparahidroksibenzoat (E 219), natrijev etilparahidroksibenzoat (E 215), kalijev sorbat (E 202), natrijev hidroksid, aspartam (E951) in saharozo.
In a comparative bioavailability study in healthy adult volunteers (n=60), 50mg of Xaluprine oral suspension was demonstrated to be bioequivalent to the reference 50mg tablet for AUC, but not Cmax. 
V primerjalni študiji biološke uporabnosti pri odraslih prostovoljcih (n = 60) se je pokazalo, da je
Monitoring of the INR (International Normalised Ratio) value is recommended during concomitant administration with oral anticoagulants. 
Med sočasno uporabo s peroralnimi antikoagulanti se priporoča spremljanje vrednosti INR
Shake the bottle vigorously for at least 30 seconds to ensure the medicine is well mixed (figure 1). 
Steklenico pred uporabo močno pretresajte vsaj 30 sekund, da se zdravilo dobro premeša
EXPIRY DATE 
Datum odpiranja
Xaluprine contains aspartame, sodium methyl parahydroxybenzoate (E219), sodium ethyl parahydroxybenzoate (E215) and sucrose 
Zdravilo Xaluprine vsebuje aspartam, natrijev metilparahidroksibenzoat (E 219), natrijev etilparahidroksibenzoat (E 215) in saharoza
4.4 Special warnings and precautions for use 
4.4 Posebna opozorila in previdnostni ukrepi Citotoksičnost in hematološko spremljanje
NAME OF THE MEDICINAL PRODUCT Xaluprine 20 mg/ml oral suspension mercaptopurine 
Navodilo za uporabo Xaluprine 20 mg/ml peroralna suspenzija merkaptopurin
100 ml. 
peroralna suspenzija 100 ml
Let the syringe dry completely before you use that syringe again for dosing. 
Brizga naj se pred naslednjo uporabo popolnoma posuši.
Multiple congenital abnormalities have been reported following maternal 6-mercatopurine treatment in combination with other chemotherapy agents. 
Pri materah, ki so se zdravile s 6-merkaptopurinom v kombinaciji z drugimi kemoterapevtiki, so poročali o več prirojenih nepravilnostih.
If you are receiving immunosuppressive therapy, taking Xaluprine could put you at greater risk of: 
Če prejemate imunosupresivno terapijo, se lahko zaradi jemanja zdravila Xaluprine poveča tveganje za: - pojav tumorjev, tudi za pojav kožnega raka.
Immunisation using a live organism vaccine has the potential to cause infection in immunocompromised hosts. 
Pri bolnikih z oslabljenim imunskim sistemom lahko po cepljenju z živim cepivom pride do okužbe.
3rd Floor, Ulysses House 
Nova Laboratories Ireland Limited 3rd Floor, Ulysses House
Amber type III glass bottle with tamper evident child-resistant closure (HDPE with expanded polyethylene liner) containing 100 ml of oral suspension. 
Rjava steklenica, ki vsebuje 100 ml peroralne suspenzije, iz stekla tipa III z zaporko, ki je varna za otroke in omogoča evidentiranje odpiranja (HDPE z razširjenim polietilenskim vložkom).
There is low entry of 6-mercaptopurine into the cerebrospinal fluid. 
Vnos 6-merkaptopurina v likvor je majhen.
Put the cap back on the bottle with the adaptor left in place. 
Nastavek pustite na steklenici in jo zaprite z zaporko.
- anti-epileptic medicines such as phenytoin, carbamazepine. 
- sulfasalazin (uporablja se pri revmatoidnem artritisu ali ulceroznem kolitisu); - zdravila proti epilepsiji, kot sta fenitoin in karbamazepin.
- Keep this medicine out of the sight and reach of children, preferably in a locked cupboard. 
Shranjevanje zdravila Xaluprine - Zdravilo shranjujte nedosegljivo otrokom, po možnosti v zaklenjeni omari.
Reliable contraception must be used to avoid pregnancy whilst you or your partner are taking Xaluprine. 
Med jemanjem zdravila Xaluprine morate vi in vaš partner uporabljati zanesljivo kontracepcijo za preprečitev zanositve.
Bone marrow suppression is reversible if 6-mercaptopurine is withdrawn early enough.. 
Supresija kostnega mozga je reverzibilna, če se zdravljenje s 6-merkaptopurinom pravočasno prekine.
Ask your doctor, pharmacist or midwife for advice. 
Posvetujte se z zdravnikom, farmacevtom ali babico.
6-mercaptopurine is also subject to S-methylation by the enzyme thiopurine S-methyltransferase (TPMT), yielding methylmercaptopurine, which is inactive. 
S-metiltransferaza (TPMT), pri čemer se tvori metilmerkaptopurin, ki pa je neaktiven.
Xanthine oxidase is the main catabolic enzyme and it converts the 6-mercaptopurine into the inactive metabolite, 6-thiouric acid. 
Ksantin-oksidaza je glavni katabolni encim in pretvarja
Reproductive system and breast disorders 
Motnje reprodukcije in dojk Redki
BSA (m2) Dose (mg) 
Odmer ek (mg)
Bone marrow suppression; leucopenia and thrombocytopenia 
Supresija kostnega mozga, levkopenija in trombocitopenija
Ask your doctor if you would like more explanation about this disease. 
Če želite podrobnejšo razlago o bolezni, se pogovorite z zdravnikom.
- Any unexpected bruising or bleeding, as this could mean that too few blood cells of a particular type are being produced 
Kakršne koli nepričakovane modrice ali krvavitve, ki bi lahko pomenile, da se ne tvori zadostno število določene vrste krvnih celic Nenadno slabo počutje (čeprav imate normalno telesno temperaturo), bolečine v trebuhu in slabost,
1 ml and 5 ml dosing syringes. 
peroralna suspenzija 100 ml steklenica nastavek za steklenico 1 ml in 5 ml brizga za odmerjanje
Renal impairment 
Edem obraza
Xaluprine contact with skin or mucous membrane must be avoided. 
Izogibajte se stiku zdravila Xaluprine s kožo ali sluznico.
NAME OF THE MEDICINAL PRODUCT Xaluprine 20 mg/ml oral suspension 
Xaluprine 20 mg/ml peroralna suspenzija